Literature DB >> 1683552

The effect of repeated oral doses of lornoxicam on antipyrine elimination in normal human volunteers.

M Ravic1, A Johnston, P Turner, F Takacs, D E Rosenow.   

Abstract

Treatment with lornoxicam 4 mg twice daily for 14 d did not produce any change in salivary antipyrine elimination in 11 of 12 healthy volunteers. Anomalous results in one subject are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683552     DOI: 10.1177/096032719101000512

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  4 in total

Review 1.  Lornoxicam. A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions.

Authors:  J A Balfour; A Fitton; L B Barradell
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.

Authors:  Yifan Zhang; Dafang Zhong; Dayong Si; Yingjie Guo; Xiaoyan Chen; Hui Zhou
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

Review 3.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.

Authors:  N M Skjodt; N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.